Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020

…, A Al Khal, E Al Kuwari, S Al Marri, M Al Masalmani… - BMJ open, 2020 - bmjopen.bmj.com
Objective To define the epidemiological curve of COVID-19 in Qatar and determine factors
associated with severe or critical illness. Design Case series of first 5685 COVID-19 cases in …

[HTML][HTML] The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study

…, MP Frenneaux, A Alkhal, HM Al-Kuwari - BMC infectious …, 2020 - Springer
Background There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at
a national level, and none after 60 days of follow up. The aim of this study was to describe …

[HTML][HTML] Testing a multicomponent lifestyle intervention for combatting childhood obesity

…, A Alsaadi, MG Al-Kuwari, S Ghuloum, H Al-Kuwari… - BMC Public Health, 2021 - Springer
Background Childhood obesity is a major global health concern. Weight-management camps
involving delivery of a program of physical activity, health education, and healthy eating …

[HTML][HTML] The Qatar Biobank: background and methods

H Al Kuwari, A Al Thani, A Al Marri, A Al Kaabi… - BMC public health, 2015 - Springer
Background The Qatar Biobank aims to collect extensive lifestyle, clinical, and biological
information from up to 60,000 men and women Qatari nationals and long-term residents (…

Patient engagement: four case studies that highlight the potential for improved health outcomes and reduced costs

…, S Henderson, PJ Howitt, M Matar, H Al Kuwari… - Health …, 2014 - healthaffairs.org
The energy of patients and members of the public worldwide who care about improving
health is a huge, but still largely unrecognized and untapped, resource. The aim of patient …

[HTML][HTML] Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar

…, HH Ayoub, Z Al Kanaani, E Al Kuwari… - … England Journal of …, 2021 - Mass Medical Soc
Background Waning of vaccine protection against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The …

[HTML][HTML] Effects of previous infection and vaccination on symptomatic omicron infections

…, P Coyle, Z Al-Kanaani, E Al-Kuwari… - … England Journal of …, 2022 - Mass Medical Soc
Background The protection conferred by natural immunity, vaccination, and both against
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the …

[HTML][HTML] Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar

…, P Coyle, Z Al-Kanaani, E Al-Kuwari… - … England Journal of …, 2022 - Mass Medical Soc
Background Waning of vaccine protection against coronavirus disease 2019 (Covid-19)
and the emergence of the omicron (or B.1.1.529) variant of the severe acute respiratory …

Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting

…, Z Al Kanaani, A Al Khal, E Al Kuwari… - Clinical Infectious …, 2021 - academic.oup.com
Background Risk of reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is unknown. We assessed the risk and incidence rate of documented SARS-CoV-2 …

[HTML][HTML] Protection against the Omicron variant from previous SARS-CoV-2 infection

…, Z Al-Kanaani, E Al-Kuwari… - … England Journal of …, 2022 - Mass Medical Soc
Protection against Omicron by Previous SARS-CoV-2 Infection Using a national Covid-19
database in Qatar, investigators found that previous SARS-CoV-2 infection provided protection …